Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Simple linctus paediatric
0309020D0AAABAB
|
Simple | Simple | Respiratory System | 2,510 |
|
Erdosteine 300mg capsules
0307000Q0AAAAAA
|
Erdosteine | Erdosteine | Respiratory System | 2,451 |
|
Acetylcysteine 600mg tablets
0307000C0AAAMAM
|
Acetylcysteine (Mucolytic) | Acetylcysteine | Respiratory System | 2,402 |
|
Desloratadine 2.5mg/5ml oral solution sugar free
0304010ABAAADAD
|
Desloratadine | Desloratadine | Respiratory System | 2,374 |
|
Tiotropium brom 2.5microg/Olodaterol 2.5microg/dose soln
0301040X0AAABAB
|
Tiotropium bromide/olodaterol | Tiotropium bromide/olodaterol | Respiratory System | 2,343 |
|
Simple linctus paediatric sugar free
0309020D0AAAFAF
|
Simple | Simple | Respiratory System | 2,330 |
|
Formoterol 12micrograms/dose dry powder inhaler
0301011E0AAACAC
|
Formoterol fumarate | Formoterol fumarate | Respiratory System | 2,298 |
|
Budesonide 400micrograms/dose dry powder inhaler
0302000K0AAAHAH
|
Budesonide (Inhalation) | Budesonide | Respiratory System | 2,276 |
|
Stalpex 50microg/dose / 500microg/dose dry powder inh
0302000N0BMAAAZ
|
Stalpex | Fluticasone propionate (Inhalation) | Respiratory System | 2,234 |
|
Aclidinium brom 396mcg/dose / Formoterol 11.8mcg/dose DP inh
0301040V0AAAAAA
|
Aclidinium bromide/formoterol | Aclidinium bromide/formoterol | Respiratory System | 2,158 |
|
Alimemazine 7.5mg/5ml oral solution
0304010Y0AAABAB
|
Alimemazine tartrate | Alimemazine tartrate | Respiratory System | 2,132 |
|
Acopair 18microgram inhalation pdr caps with NeumoHaler
0301020Q0BDAAAA
|
Acopair | Tiotropium bromide | Respiratory System | 2,103 |
|
Avenor 25micrograms/dose / 125micrograms/dose inhaler
0302000N0BPABBF
|
Avenor | Fluticasone propionate (Inhalation) | Respiratory System | 2,040 |
|
Mucodyne 250mg/5ml syrup
0307000J0BBABAC
|
Mucodyne | Carbocisteine | Respiratory System | 2,038 |
|
Salbutamol 2.5mg/Ipratropium brom 500mcg/2.5ml neb liq vials
0301040R0AAABAB
|
Salbutamol/ipratropium bromide | Salbutamol | Respiratory System | 2,036 |
|
Soprobec 250micrograms/dose inhaler
0302000C0BTADBW
|
Soprobec | Beclometasone dipropionate | Respiratory System | 1,916 |
|
WockAIR 160micrograms/dose / 4.5micrograms/dose dry pdr inh
0302000K0BJAAAM
|
WockAIR | Budesonide | Respiratory System | 1,859 |
|
Beclometasone 200micrograms/dose dry powder inhaler
0302000C0AABUBU
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 1,857 |
|
Mucodyne 375mg capsules
0307000J0BBAAAA
|
Mucodyne | Carbocisteine | Respiratory System | 1,750 |
|
Glycopyrronium 7.2microg/Formoterol 5microg/dose inh CFCfree
0301040AAAAAAAA
|
Glycopyrronium/formoterol | Glycopyrronium/formoterol | Respiratory System | 1,729 |
|
Avenor 25micrograms/dose / 50micrograms/dose inhaler
0302000N0BPAABE
|
Avenor | Fluticasone propionate (Inhalation) | Respiratory System | 1,694 |
|
Fluticasone propionate 250micrograms/dose dry powder inhaler
0302000N0AAATAT
|
Fluticasone propionate (Inhalation) | Fluticasone propionate (Inhalation) | Respiratory System | 1,646 |
|
Beclometasone 200micrograms/dose inhaler CFC free
0302000C0AABVBV
|
Beclometasone dipropionate (Inhalation) | Beclometasone dipropionate | Respiratory System | 1,643 |
|
Combivent nebuliser liquid 2.5ml UDVs
0301040R0BBABAB
|
Combivent | Salbutamol | Respiratory System | 1,601 |
|
Phenergan 10mg tablets
0304010W0BBAAAD
|
Phenergan (Systemic) | Promethazine hydrochloride | Respiratory System | 1,560 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.